Epidemiological, Clinical, Microbiological and Outcome Description of Patients With Klebsiella sp Meningitis

NCT ID: NCT03967210

Last Updated: 2021-08-23

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

132 participants

Study Classification

OBSERVATIONAL

Study Start Date

2019-07-05

Study Completion Date

2020-01-13

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Klebsiella pneumoniae is implicated in the occurrence of severe pneumonia. Most Klebsiella pneumoniae infections are associated with care and occur in patients with compromised immune defenses. More recently, cases of hepatic abscess and acute community meningitis related to strains of Klebsiella pneumoniae have been reported. The mortality of these infections is important, most often due to a delayed diagnosis. The poor prognostic factors reported in the literature for very low numbers are: advanced age, coma, septic shock, glyceryachia \<10mg / dL and proteinuria\> 750 mg / dL. In addition, no study has specifically focused on the factors of occurrence and factors associated with Klebsiella sp. Indeed, meningitis related to Klebsiella pneumoniae seems to be a rare but probably underestimated event whose risk factors, clinical presentation, microbiological are little known and the treatment modalities of this severe infection are not codified.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Meningitis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

RETROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Man or Woman whose age ≥ 18 years
* Patient with meningitis Klebsiella sp., hospitalized in one of the hospitals of the Clinical Microbiology Group
* Francophone patient

Exclusion Criteria

* Patient under tutorship or curatorship
* Patient deprived of liberty
* Patient under safeguard of justice
* Patient opposing his participation
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Fondation Hôpital Saint-Joseph

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Benoit PILMIS, MD

Role: STUDY_DIRECTOR

Fondation Hôpital Saint-Joseph

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

CHU Brest

Brest, , France

Site Status

CHU Caen

Caen, , France

Site Status

Hôpital henri Mondor

Créteil, , France

Site Status

CHU Lyon

Lyon, , France

Site Status

CHU Nantes

Nantes, , France

Site Status

CHU Nice

Nice, , France

Site Status

Hôpital Lariboisière

Paris, , France

Site Status

Groupe Hospitalier Paris Saint-Joseph

Paris, , France

Site Status

Hôpital Cochin

Paris, , France

Site Status

CHU Kremlin Bicetre

Paris, , France

Site Status

Hôpital Foch

Paris, , France

Site Status

Hôpital Necker Enfants Malades

Paris, , France

Site Status

Hôpital Sainte Anne

Paris, , France

Site Status

CHU Poitiers

Poitiers, , France

Site Status

CHU Reims

Reims, , France

Site Status

CHU Rennes

Rennes, , France

Site Status

CHU Strasbourg

Strasbourg, , France

Site Status

CHU Tours

Tours, , France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

KlebsieLCR

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.